Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Nat Prod ; 80(5): 1347-1353, 2017 05 26.
Artigo em Inglês | MEDLINE | ID: mdl-28493718

RESUMO

Neem (Azadirachta indica) is a well-known medicinal and insecticidal plant. Although previous studies have reported the antiulcer activity of neem leaf extract, the lead compound is still unidentified. The present study reports tamarixetin 3-O-ß-d-glucopyranoside (1) from a methanol extract of neem leaves and its gastroprotective activity in an animal model. Compound 1 showed significant protection against indomethacin-induced gastric ulceration in mice in a dose-dependent manner. Moreover, ex vivo and circular dichroism studies confirmed that 1 inhibited the enzyme matrix metalloproteinase-9 (MMP-9) activity with an IC50 value of ca. 50 µM. Molecular docking and dynamics showed the binding of 1 into the pocket of the active site of MMP-9, forming a coordination complex with the catalytic zinc, thus leading to inhibition of MMP-9 activity.


Assuntos
Antiulcerosos/farmacologia , Azadirachta/química , Dissacarídeos/isolamento & purificação , Dissacarídeos/farmacologia , Indometacina/farmacologia , Metaloproteinase 9 da Matriz/química , Quercetina/análogos & derivados , Animais , Antiulcerosos/química , Dissacarídeos/química , Indometacina/química , Metaloproteinase 9 da Matriz/metabolismo , Camundongos , Simulação de Acoplamento Molecular , Estrutura Molecular , Fitoterapia , Folhas de Planta , Quercetina/química , Quercetina/isolamento & purificação , Quercetina/farmacologia
2.
Antimicrob Agents Chemother ; 60(10): 6281-93, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27503653

RESUMO

Visceral leishmaniasis is a fatal parasitic disease, and there is an emergent need for development of effective drugs against this neglected tropical disease. We report here the development of a novel spirooxindole derivative, N-benzyl-2,2'α-3,3',5',6',7',7α,α'-octahydro-2methoxycarbonyl-spiro[indole-3,3'-pyrrolizidine]-2-one (compound 4c), which inhibits Leishmania donovani topoisomerase IB (LdTopIB) and kills the wild type as well as drug-resistant parasite strains. This compound inhibits catalytic activity of LdTopIB in a competitive manner. Unlike camptothecin (CPT), the compound does not stabilize the DNA-topoisomerase IB cleavage complex; rather, it hinders drug-DNA-enzyme covalent complex formation. Fluorescence studies show that the stoichiometry of this compound binding to LdTopIB is 2:1 (mole/mole), with a dissociation constant of 6.65 µM. Molecular docking with LdTopIB using the stereoisomers of compound 4c produced two probable hits for the binding site, one in the small subunit and the other in the hinge region of the large subunit of LdTopIB. This spirooxindole is highly cytotoxic to promastigotes of L. donovani and also induces apoptosis-like cell death in the parasite. Treatment with compound 4c causes depolarization of mitochondrial membrane potential, formation of reactive oxygen species inside parasites, and ultimately fragmentation of nuclear DNA. Compound 4c also effectively clears amastigote forms of wild-type and drug-resistant parasites from infected mouse peritoneal macrophages but has less of an effect on host macrophages. Moreover, compound 4c showed strong antileishmanial efficacies in the BALB/c mouse model of leishmaniasis. This compound potentially can be used as a lead for developing excellent antileishmanial agents against emerging drug-resistant strains of the parasite.


Assuntos
Antiprotozoários/farmacologia , DNA Topoisomerases Tipo I/química , Leishmania donovani/efeitos dos fármacos , Alcaloides de Pirrolizidina/farmacologia , Compostos de Espiro/farmacologia , Inibidores da Topoisomerase I/farmacologia , Animais , Antiprotozoários/química , Sítios de Ligação , DNA Topoisomerases Tipo I/metabolismo , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos/métodos , Resistência a Medicamentos/efeitos dos fármacos , Feminino , Humanos , Leishmania donovani/crescimento & desenvolvimento , Leishmaniose Visceral/tratamento farmacológico , Fígado/efeitos dos fármacos , Fígado/parasitologia , Macrófagos Peritoneais/efeitos dos fármacos , Macrófagos Peritoneais/parasitologia , Camundongos Endogâmicos BALB C , Simulação de Acoplamento Molecular , Alcaloides de Pirrolizidina/química , Compostos de Espiro/química , Baço/efeitos dos fármacos , Baço/parasitologia , Inibidores da Topoisomerase I/química , Inibidores da Topoisomerase I/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA